Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion type Assertion NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_head.
- NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion description "[We found that anisomycin treatment (10-15 nM) alone had no effect on the level of apoptosis, but a combination treatment of anisomycin and TRAIL significantly increased the level of apoptosis in human renal carcinoma (Caki, ACHN and A498), human glioma (U251MG), and human breast carcinoma (MDA-MB-361 and MCF7) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_provenance.
- NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion evidence source_evidence_literature NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_provenance.
- NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion SIO_000772 23261849 NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_provenance.
- NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion wasDerivedFrom befree-2016 NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_provenance.
- NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_assertion wasGeneratedBy ECO_0000203 NP1038086.RA3FIq_p2oy4Q_mVtS4XnrLzbVVHneXgzxaU-GYCnK1tc130_provenance.